HALEOS LABS LIMITED

Healthcare · Pharmaceuticals & Biotechnology

NSE: HALEOSLABS BSE: 540679

About HALEOS LABS LIMITED

No company profile on record yet.

Key facts

BSE symbol540679
NSE symbolHALEOSLABS
ISININE320X01016
CINL74930TG2006PLC050223
Listing date17 Aug 2017
Fiscal year end31 Mar
SectorHealthcare
IndustryPharmaceuticals & Biotechnology
AuditorCSB Associates (C Sudhir Babu)
Registered officePLOT NO.19-III, ROAD NO.71, JUBILEE HILLS, OPP. BHARATIYA VIDYA BHAVAN PUBLIC SCHOOL
Registrar & transfer agentAARTHI CONSULTANTS PRIVATE LIMITED. 1-2-285, DOMALGUDA

Financial performance

Full financials →
Fiscal yearMar 26Mar 25Mar 24Mar 23Mar 22
Total income (before exceptional items)303†337†304†318†348†
Net profit1821131325†

₹ Crore. † Summed from the four quarterly filings of that fiscal year.

Board of directors

Current board roster from exchange filings. Director remuneration is not in our data, so it isn't shown.

NameDesignationTerm end
SUDEEPTHI GOPINEEDIExecutive DirectorJune 30, 2026
VEERA VENKATA SATYANARAYANA MURTHY TALLURIExecutive DirectorJune 30, 2026
VENKATA PRAVEEN TALLURIExecutive DirectorJune 30, 2026
MANNAM MALAKONDAIAHIndependent DirectorJune 30, 2026
SARATH KUMAR PAKALAPATIIndependent DirectorJune 30, 2026
SRINIVAS SAMAVEDAMIndependent DirectorJune 30, 2026

Management, subsidiaries and brands

Key management names, their remuneration, subsidiaries and brand listings are not in the exchange filings we ingest yet, so they are not shown here rather than estimated.